Axogen Statistics

Total Valuation

Axogen has a market cap or net worth of GBP 587.80 million. The enterprise value is 616.85 million.

Market Cap	587.80M
Enterprise Value	616.85M

Important Dates

The last earnings date was Tuesday, March 4, 2025.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.22%
Shares Change (QoQ)	+9.53%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	7.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 96.24, with an EV/FCF ratio of 538.53.

EV / Earnings	-77.50
EV / Sales	4.26
EV / EBITDA	96.24
EV / EBIT	n/a
EV / FCF	538.53

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.68.

Current Ratio	3.24
Quick Ratio	1.88
Debt / Equity	0.68
Debt / EBITDA	8.57
Debt / FCF	49.57
Interest Coverage	-0.40

Financial Efficiency

Return on equity (ROE) is -9.99% and return on invested capital (ROIC) is -1.20%.

Return on Equity (ROE)	-9.99%
Return on Assets (ROA)	-1.03%
Return on Invested Capital (ROIC)	-1.20%
Return on Capital Employed (ROCE)	-1.90%
Revenue Per Employee	331,062
Profits Per Employee	-17,608
Employee Count	452
Asset Turnover	0.94
Inventory Turnover	1.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +113.89% in the last 52 weeks. The beta is 0.76, so Axogen's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+113.89%
50-Day Moving Average	17.92
200-Day Moving Average	13.01
Relative Strength Index (RSI)	44.65
Average Volume (20 Days)	1,182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.49

Income Statement

In the last 12 months, Axogen had revenue of GBP 149.64 million and -7.96 million in losses. Loss per share was -0.18.

Revenue	149.64M
Gross Profit	113.41M
Operating Income	-2.63M
Pretax Income	-7.96M
Net Income	-7.96M
EBITDA	2.75M
EBIT	-2.63M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 26.74 million in cash and 56.78 million in debt, giving a net cash position of -30.04 million.

Cash & Cash Equivalents	26.74M
Total Debt	56.78M
Net Cash	-30.04M
Net Cash Per Share	n/a
Equity (Book Value)	83.00M
Book Value Per Share	1.88
Working Capital	54.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.62 million and capital expenditures -2.48 million, giving a free cash flow of 1.15 million.

Operating Cash Flow	3.62M
Capital Expenditures	-2.48M
Free Cash Flow	1.15M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.79%, with operating and profit margins of -1.75% and -5.32%.

Gross Margin	75.79%
Operating Margin	-1.75%
Pretax Margin	-5.32%
Profit Margin	-5.32%
EBITDA Margin	1.84%
EBIT Margin	-1.75%
FCF Margin	0.77%

Dividends & Yields

Axogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.22%
Shareholder Yield	-3.22%
Earnings Yield	-1.35%
FCF Yield	0.19%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Axogen has an Altman Z-Score of 1.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.97
Piotroski F-Score	n/a